Adjuvant chemotherapy was most beneficial in patients diagnosed with triple-negative disease and least beneficial in oestrogen receptor positive patients, where the benefit failed to reach statistical significance.
1
—
—
Adjuvant chemotherapy was most beneficial in patients diagnosed with triple-negative disease and least beneficial in oestrogen receptor positive patients, where the benefit failed to reach statistical significance.